(Q34416863)

2 August 2017

Propranolol disposition in patients with hepatosplenic schistosomiasis (English)

1 reference

2 August 2017

0 references

Homeida MM

1

1 reference

2 August 2017

Ali HM

series ordinal

2

1 reference

2 August 2017

Arbab BM

series ordinal

3

1 reference

2 August 2017

Harron DW

series ordinal

4

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 September 1987

1 reference

British Journal of Clinical Pharmacology

2 August 2017

1 reference

2 August 2017

24

1 reference

2 August 2017

3

1 reference

2 August 2017

393-396

1 reference

Disposition of oral metronidazole in hepatic cirrhosis and in hepatosplenic schistosomiasis

2 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1386264

Propranolol for prevention of recurrent gastrointestinal bleeding in patients with cirrhosis: a controlled study

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1386264

Hepatic disease and drug pharmacokinetics

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1386264

Calcium Antagonists Pharmacokinetic Properties

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1386264

The pharmacokinetics of antipyrine in patients with graded severity of schistosomiasis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1386264

Oxamniquine pharmacokinetics in hepatosplenic schistosomiasis in the Sudan

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1386264

A study of factors influencing drug disposition in chronic liver disease, using the model drug (+)-propranolol

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1386264

Drug metabolism in hepatosplenic schistosomiasis in the Sudan: a study with antipyrine

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1386264

Clinical Pharmacokinetics of Propranolol

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1386264

The disposition of propranolol. I. Elimination during oral absorption in man

6 July 2018

1 reference

12 December 2020

The influence of cirrhosis on steady-state blood concentrations of unbound propranolol after oral administration

1 reference

12 December 2020

Altered drug metabolism in hepatosplenic schistosomiasis

1 reference

12 December 2020

Propranolol--a medical treatment for portal hypertension?

1 reference

12 December 2020

Hepatic schistosomiasis

1 reference

12 December 2020

Drug therapy of portal hypertension and oesophageal varices

1 reference

12 December 2020

10.1111/J.1365-2125.1987.TB03187.X

Identifiers

DOI

1 reference

2 August 2017

1 reference

2 August 2017

1 reference